MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
attributable to serina
-$19,182K
(-72.17%↓ Y/Y)
Net loss
attributable to...
-$33K
(50.00%↑ Y/Y)
Net loss
-$19,215K
(-71.46%↓ Y/Y)
Change in fair value of
warrants liabilities
-$4,263K
(67.60%↑ Y/Y)
Gain on warrants
expiration
$724K
Other income, net
$51K
(-77.63%↓ Y/Y)
Loss before income
taxes
-$19,197K
Provision for income taxes
$18K
Total other income,
net
$4,825K
(-17.39%↓ Y/Y)
Revenue From Contract
With Customer...
$130K
Interest expense
$213K
(-59.51%↓ Y/Y)
Loss from operations
-$24,022K
(-40.91%↓ Y/Y)
Total revenues
$130K
(132.14%↑ Y/Y)
Total operating
expenses
$24,152K
(41.21%↑ Y/Y)
Research and development
$13,155K
(75.87%↑ Y/Y)
General and
administrative
$10,997K
(14.27%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Serina Therapeutics, Inc. (SER)
Serina Therapeutics, Inc. (SER)